See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $20.4B | 7.6x | 31.6x | |
| $11.9B | 649.4x | -10.6x | |
| $6.1B | 4.4x | 17.9x | |
| $4.1B | 15.8x | 38.2x | |
| $3.7B | n/a | n/a | |
| $3.5B | 23.9x | -65.8x | |
| $2.7B | n/a | n/a | |
| $2.7B | 2.3x | 8.4x | |
| $2.1B | 39.0x | -8.0x | |
| $1.6B | 4.6x | n/a | |
| $1.1B | 35.8x | -4.7x | |
| $1.1B | 31.9x | -149.0x | |
| $974M | 11.9x | n/a | |
| $778M | 150.0x | -5.8x | |
| $551M | 14.8x | 57.0x | |
| $447M | 36.0x | 3236.2x | |
| $370M | n/a | -14.3x | |
| $319M | 7.1x | -17.5x | |
| $272M | 3.2x | 11.6x | |
| $212M | n/a | n/a | |
| $171M | 6.8x | n/a | |
| $149M | 28.7x | n/a | |
| $139M | 4.3x | -0.9x | |
| $133M | 9.8x | -9.8x | |
| $108M | n/a | n/a | |
| $99.0M | 4.5x | -79.1x | |
| $94.3M | 13.5x | -26.1x | |
| $70.5M | 19.5x | -3.1x | |
| $64.1M | 1526.0x | n/a | |
| $60.1M | n/a | n/a | |
| $58.6M | n/a | n/a | |
| $50.0M | n/a | n/a | |
| $49.4M | 7.4x | -12.6x | |
| $47.4M | 50.0x | n/a | |
| $46.7M | 17.3x | n/a | |
| $33.9M | n/a | -2.4x | |
| $29.1M | 388.5x | n/a | |
| $27.9M | 22.9x | n/a | |
| $15.9M | n/a | n/a | |
| $13.9M | 19.0x | n/a | |
| $13.0M | n/a | n/a | |
| $2.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems